Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
The British Journal of Radiology
|
February 5, 2025
Clinical and Research Applications of FAPI Tracers: A Review
Mélanie Desaulniers, Étienne Rousseau, Kim M Pabst
Seminars in Nuclear Medicine
|
July 17, 2025
The Value of FAPI PET/CT in Cholangiocarcinoma and Pancreatic Cancer: An Update
Kim M Pabst, Wolfgang P Fendler, Leonie S Jochheim, et al.
Oncology Research and Treatment
|
November 24, 2021
The Future Role of PET Imaging in Metastatic Breast Cancer
Kim M Pabst, Thomas Decker, David Kersting, et al.
Seminars in Nuclear Medicine
|
December 18, 2025
FAPI PET imaging value in radiotherapy planning and assessment in head and neck cancers
Qaid Ahmed Shagera, Ayça Arçay Öztürk, Kim M Pabst, et al.
Annals of Nuclear Medicine
|
March 12, 2025
FAPI radiopharmaceuticals in nuclear oncology and theranostics of solid tumours: are we nearer to surrounding the hallmarks of cancer?
Irene García Megías, Ludmila Santiago Almeida, Adriana K Calapaquí Terán, et al.
EJNMMI Research
|
July 18, 2024
[<sup>68</sup>Ga]Ga-FAPI versus 2-[<sup>18</sup>F]FDG PET/CT in patients with autoimmune thyroiditis: a case control study
Kim M Pabst, Lukas Kessler, Justin Ferdinandus, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 21, 2025
Prognostic value of [<sup>18</sup>F]FDG- and PSMA-PET in patients evaluated for [<sup>177</sup>Lu]Lu-PSMA therapy of mCRPC
Tugce Telli, Leonor Lopes, Madeleine Karpinski, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 21, 2023
Oncologic Staging with <sup>68</sup>Ga-FAPI PET/CT Demonstrates a Lower Rate of Nonspecific Lymph Node Findings Than <sup>18</sup>F-FDG PET/CT
Tristan T Demmert, Kelsey L Pomykala, Helena Lanzafame, et al.
Cancers
|
September 9, 2023
Bilobar Radioembolization Carries the Risk of Radioembolization-Induced Liver Disease in the Treatment of Advanced Hepatocellular Carcinoma: Safety and Efficacy Comparison to Systemic Therapy with Atezolizumab/Bevacizumab
Matthias Jeschke, Johannes M Ludwig, Catherine Leyh, et al.
PET Clinics
|
March 30, 2023
Fibroblast Activation Protein Inhibitor Theranostics: The Case for Use in Sarcoma
Rainer Hamacher, Helena Lanzafame, Ilektra A Mavroeidi, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
The British Journal of Radiology
|
February 5, 2025
Clinical and Research Applications of FAPI Tracers: A Review
Mélanie Desaulniers, Étienne Rousseau, Kim M Pabst
Seminars in Nuclear Medicine
|
July 17, 2025
The Value of FAPI PET/CT in Cholangiocarcinoma and Pancreatic Cancer: An Update
Kim M Pabst, Wolfgang P Fendler, Leonie S Jochheim, et al.
Oncology Research and Treatment
|
November 24, 2021
The Future Role of PET Imaging in Metastatic Breast Cancer
Kim M Pabst, Thomas Decker, David Kersting, et al.
Seminars in Nuclear Medicine
|
December 18, 2025
FAPI PET imaging value in radiotherapy planning and assessment in head and neck cancers
Qaid Ahmed Shagera, Ayça Arçay Öztürk, Kim M Pabst, et al.
Annals of Nuclear Medicine
|
March 12, 2025
FAPI radiopharmaceuticals in nuclear oncology and theranostics of solid tumours: are we nearer to surrounding the hallmarks of cancer?
Irene García Megías, Ludmila Santiago Almeida, Adriana K Calapaquí Terán, et al.
EJNMMI Research
|
July 18, 2024
[<sup>68</sup>Ga]Ga-FAPI versus 2-[<sup>18</sup>F]FDG PET/CT in patients with autoimmune thyroiditis: a case control study
Kim M Pabst, Lukas Kessler, Justin Ferdinandus, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 21, 2025
Prognostic value of [<sup>18</sup>F]FDG- and PSMA-PET in patients evaluated for [<sup>177</sup>Lu]Lu-PSMA therapy of mCRPC
Tugce Telli, Leonor Lopes, Madeleine Karpinski, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 21, 2023
Oncologic Staging with <sup>68</sup>Ga-FAPI PET/CT Demonstrates a Lower Rate of Nonspecific Lymph Node Findings Than <sup>18</sup>F-FDG PET/CT
Tristan T Demmert, Kelsey L Pomykala, Helena Lanzafame, et al.
Cancers
|
September 9, 2023
Bilobar Radioembolization Carries the Risk of Radioembolization-Induced Liver Disease in the Treatment of Advanced Hepatocellular Carcinoma: Safety and Efficacy Comparison to Systemic Therapy with Atezolizumab/Bevacizumab
Matthias Jeschke, Johannes M Ludwig, Catherine Leyh, et al.
PET Clinics
|
March 30, 2023
Fibroblast Activation Protein Inhibitor Theranostics: The Case for Use in Sarcoma
Rainer Hamacher, Helena Lanzafame, Ilektra A Mavroeidi, et al.
Page
of 4